Dexmedetomidine Infusion for the Management of Opioid-Induced Hyperalgesia

Abstract

The cases presented provide support for the clinical utility of alpha-2 agonists during opioid dose reduction in patients with OIH as well suggesting that they may contribute to the recovery of normal nociceptive and antinociceptive responses.